NVAX
NASDAQ · Biotechnology
Novavax Inc
$7.32
-0.12 (-1.61%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+294.5% upside
Low Target
$20.35
Average Target
$28.88
High Target
$29.25
Current Price
$7.32
Current
$7.32
$7.32
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Scenario Analysis
Bear Case
$20.35
178.0%
Low target
Base Case
$28.88
+294.5%
Avg target
Bull Case
$29.25
+299.6%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$11.97
-38.8% from high
52-Week Low
$6.20
+18.1% from low
Target vs 52W High
$28.88
+141.3% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.41
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |